The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating stromal cells as a potential blood-based biomarker for screening invasive solid tumors.
 
Daniel Adams
Employment - Creatv MicroTech
Stock and Other Ownership Interests - Creatv MicroTech
 
Steven H. Lin
Honoraria - AstraZeneca/MedImmune
Speakers' Bureau - Varian Medical Systems
Research Funding - Genentech/Roche; Hitachi Chemical; New River Labs; STCube Pharmaceuticals Inc.
 
Harvey I. Pass
Honoraria - Genentech (I); Genomic Health (I)
Consulting or Advisory Role - AstraZeneca
Research Funding - Biodesix (Inst); Celera; Genentech; Nodality; SomaLogic
Patents, Royalties, Other Intellectual Property - Patent Pending, use of fibulin for the diagnosis of mesothelioma Patent Pending, use of HMGB1 for the diagnosis of mesothelioma, with University of Hawaii Patent Pending, use of osteopontin for the diagnosis of mesothelioma, with Wayne State University (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche
 
Saranya Chumsri
Consulting or Advisory Role - Eisai; Immunomedics; Novartis; Puma Biotechnology; Syndax
Research Funding - Array BioPharma; Merck
 
Rena G. Lapidus
Consulting or Advisory Role - Integrated Biotherapeutics
 
Martin Edelman
Stock and Other Ownership Interests - Biomarker Strategies; Neumedicines
Consulting or Advisory Role - ARMO BioSciences; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Syndax; WindMIL
Research Funding - Apexigen (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Nektar (Inst); United Therapeutics (Inst); Windmil (Inst)
Patents, Royalties, Other Intellectual Property - Patent application for radiopharmaceutical to treat small cell lung cancer. (Inst)
Travel, Accommodations, Expenses - ARMO BioSciences; BerGenBio; BerGenBio; Bristol-Myers Squibb
Other Relationship - AstraZeneca/MedImmune; Boehringer Ingelheim; Lilly; Takeda
 
Raymond C. Bergan
Stock and Other Ownership Interests - Third Coast Therapeutics
Patents, Royalties, Other Intellectual Property - I hold several patents, and currently have two pending, related to small molecule therapeutics that inhibit cancer cell motility, bone destruction and screening assays for potentially active drugs.
(OPTIONAL) Uncompensated Relationships - Hebei Provence Scientific Foundation
 
Susan Tsai
No Relationships to Disclose
 
Rebecca Aft
No Relationships to Disclose
 
Sreeraj Pillai
No Relationships to Disclose
 
Mark Watson
No Relationships to Disclose
 
Amy K. Kim
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Kazuaki Chikamatsu
No Relationships to Disclose
 
Masanori Hayashi
No Relationships to Disclose
 
David M Loeb
No Relationships to Disclose
 
Navin R. Pinto
No Relationships to Disclose
 
R. Katherine Alpaugh
No Relationships to Disclose
 
Cha-Mei Tang
Employment - Creatv MicroTech
Leadership - Creatv MicroTech
Stock and Other Ownership Interests - Creatv MicroTech
 
Thai Huu Ho
Consulting or Advisory Role - Cardinal Health; Exelixis; Ipsen; Pfizer; Roche/Genentech; Surface Oncology
Research Funding - Novartis
 
Jeffrey R Marks
No Relationships to Disclose